RT Journal Article
SR Electronic
T1 When the Guillain-Barré patient fails to respond to treatment
JF Practical Neurology
JO Pract Neurol
FD BMJ Publishing Group Ltd
SP 227
OP 230
DO 10.1136/jnnp.2009.176578
VO 9
IS 4
A1 Winer, J B
YR 2009
UL http://pn.bmj.com/content/9/4/227.abstract
AB Most patients with Guillain-Barré syndrome (GBS) respond to treatment with intravenous immunoglobulin, but it is not uncommon for some to continue to deteriorate for a period after treatment has been started. This may reflect the natural history of the disease, or an error in diagnosis. This article reflects my own view of what to do in this situation, with a review of what few data there are to guide decision making.